Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'

por Willemse, P M, Burggraaf, J, Hamdy, N A T, Osanto, S
Publicado 2013

Cisplatin in breast cancer.

por Willemse, P., Sleijfer, D. T., Mulder, N. H., de Vries, E. G.
Publicado 1993

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.

por Mulder, N. H., Willemse, P. H., Schraffordt Koops, H., de Vries, E. G., Sleijfer, D. T.
Publicado 1990

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.

por Mulder, N. H., de Vries, E. G., Sleijfer, D. T., Schraffordt Koops, H., Willemse, P. H.
Publicado 1992

Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.

por Mulder, N. H., van der Graaf, W. T., Willemse, P. H., Koops, H. S., de Vries, E. G., Sleijfer, D. T.
Publicado 1994

Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.

por Sleijfer, S., Willemse, P. H., de Vries, E. G., van der Graaf, W. T., Schraffordt Koops, H., Mulder, N. H.
Publicado 1996

Feasibility of a dose-intensive CMF regimen with granulocyte colony-stimulating factor as adjuvant therapy in premenopausal patients with node-positive breast cancer

por Bos, A M E, Graaf, H de, Vries, E G E de, Piersma, H, Willemse, P H B
Publicado 2000

Guideline adherence for early breast cancer before and after introduction of the sentinel node biopsy

por Schaapveld, M, de Vries, E G E, Otter, R, de Vries, J, Dolsma, W V, Willemse, P H B
Publicado 2005

Paclitaxel, ifosfamide and cisplatin with granulocyte colony-stimulating factor or recombinant human interleukin 3 and granulocyte colony-stimulating factor in ovarian cancer: a fe...

por Veldhuis, G. J., Willemse, P. H., Beijnen, J. H., Boonstra, H., Piersma, H., van der Graaf, W. T., de Vries, E. G.
Publicado 1997

Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer.

por de Graaf, H., Dolsma, W. V., Willemse, P. H., van der Graaf, W. T., Sleijfer, D. T., de Vries, E. G., Mulder, N. H.
Publicado 1997

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

por Gietema, J. A., de Vries, E. G., Sleijfer, D. T., Willemse, P. H., Guchelaar, H. J., Uges, D. R., Aulenbacher, P., Voegeli, R., Mulder, N. H.
Publicado 1993

Quantitative ultrasound of the calcaneus (QUS): A valuable tool in the identification of patients with non-metastatic prostate cancer requiring screening for osteoporosis

por Nieuwkamer, B.B., Vrouwe, J.P.M., Willemse, P.M., Nicolai, M.P.J., Bevers, R.F.M., Pelger, R.C.M., Hamdy, N.A.T., Osanto, S.
Publicado 2023

A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancer.

por de Vries, E. G., Gietema, J. A., Workman, P., Scott, J. E., Crawshaw, A., Dobbs, H. J., Dennis, I., Mulder, N. H., Sleijfer, D. T., Willemse, P. H.
Publicado 1993

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.

por Biesma, B., Willemse, P. H., Mulder, N. H., Verschueren, R. C., Kema, I. P., de Bruijn, H. W., Postmus, P. E., Sleijfer, D. T., de Vries, E. G.
Publicado 1992

Ovarian cysts in women receiving tamoxifen for breast cancer

por Mourits, M J E, Vries, E G E de, Willemse, P H B, Hoor, K A ten, Hollema, H, Sluiter, W J, Bruijn, H W A de
Publicado 1999

Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide.

por de Jong, R. S., Mulder, N. H., Uges, D. R., Kaul, S., Winograd, B., Sleijfer DTh, Groen, H. J., Willemse, P. H., van der Graaf, W. T., de Vries, E. G.
Publicado 1997

Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapy

por Mourits, M J, Böckermann, I, de Vries, E G, van der Zee, A G, ten Hoor, K A, van der Graaf, W T, Sluiter, W J, Willemse, P H
Publicado 2002

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.

por Gietema, J. A., Veldhuis, G. J., Guchelaar, H. J., Willemse, P. H., Uges, D. R., Cats, A., Boonstra, H., van der Graaf, W. T., Sleijfer, D. T., de Vries, E. G.
Publicado 1995

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

por Willemse, P M, Burggraaf, J, Hamdy, N A T, Weijl, N I, Vossen, C Y, van Wulften, L, van Steijn-van Tol, A Q M J, Rosendaal, F R, Osanto, S
Publicado 2013

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors

por Willemse, P M, Burggraaf, J, Hamdy, N A T, Weijl, N I, Vossen, C Y, van Wulften, L, van Steijn-van Tol, A Q M J, Rosendaal, F R, Osanto, S
Publicado 2013